• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于四种预后相关长链非编码RNA(PALnc)的风险评分系统可反映免疫细胞浸润情况,并预测胰腺癌患者的生存情况。

A four prognosis-associated lncRNAs (PALnc) based risk score system reflects immune cell infiltration and predicts patient survival in pancreatic cancer.

作者信息

Zhuang Hongkai, Huang Shanzhou, Zhou Zixuan, Ma Zuyi, Zhang Zedan, Zhang Chuanzhao, Hou Baohua

机构信息

Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, No. 106 Zhongshan Er Road, Guangzhou, 510080 China.

Shantou University of Medical College, Shantou, 515000 Guangdong China.

出版信息

Cancer Cell Int. 2020 Oct 9;20:493. doi: 10.1186/s12935-020-01588-y. eCollection 2020.

DOI:10.1186/s12935-020-01588-y
PMID:33061845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7547431/
Abstract

BACKGROUND

Pancreatic cancer (PC) is one of the most common cancers and the leading cause of cancer-related death worldwide. Exploring novel predictive biomarkers for PC patients' prognosis is in urgent need.

METHODS

In the present study, we conducted Cox proportional hazards regression to identify critical prognosis-associated lncRNAs (PALncs) in TCGA PC dataset. Based on the results of multivariate analysis, a PALnc-based risk score system was established, and validated in GSE62452 dataset. The validity and reliability of the risk score system for prognosis of PC were evaluated through ROC analysis. And function enrichment analyses for the PALncs were also performed.

RESULT

In the multivariate analysis, four PALncs (LINC00476, C9orf163, LINC00346 and DSCR9) were screened out to develop a risk score system, which showed a high AUC at 3 and 5 years overall survival (0.785 at 3 year OS, 0.863 at 5 year OS) in TCGA datasets. And the ROC analysis of the risk score system for RFS in TCGA dataset revealed that AUC for RFS was 0.799 at 3 years and 0.909 at 5 years. Further, the AUC for OS in the validation cohort was 0.705 at 3 years and 0.959 at 5 years. Furthermore, the functional enrichment analysis revealed that these PALncs may be involved in various pathways related to cancer, including Ras family activation, autophagy in cancer, MAPK signaling pathway, HIF-1 signaling pathway, PI3K-Akt signaling pathway, etc. And correlation analysis of these tumor infiltrating immune cells and risk score system revealed that the infiltration level of B cell naïve, plasma cells, and CD8+ T cells are negatively correlated to the risk score system, while macrophages M2 positively correlated to the risk score system.

CONCLUSION

Our study established a four PALncs based risk score system, which reflects immune cell infiltration and predicts patient survival for PC.

摘要

背景

胰腺癌(PC)是全球最常见的癌症之一,也是癌症相关死亡的主要原因。迫切需要探索用于预测PC患者预后的新型生物标志物。

方法

在本研究中,我们进行Cox比例风险回归分析,以在TCGA PC数据集中识别关键的预后相关lncRNA(PALnc)。基于多变量分析结果,建立了基于PALnc的风险评分系统,并在GSE62452数据集中进行验证。通过ROC分析评估PC预后风险评分系统的有效性和可靠性。还对PALnc进行了功能富集分析。

结果

在多变量分析中,筛选出四个PALnc(LINC00476、C9orf163、LINC00346和DSCR9)以建立风险评分系统,该系统在TCGA数据集中3年和5年总生存期显示出较高的AUC(3年总生存期时为0.785,5年总生存期时为0.863)。TCGA数据集中风险评分系统对无复发生存期(RFS)的ROC分析显示,3年时RFS的AUC为0.799,5年时为0.909。此外,验证队列中3年总生存期的AUC为0.705,5年时为0.959。此外,功能富集分析表明,这些PALnc可能参与多种与癌症相关的途径,包括Ras家族激活、癌症中的自噬、MAPK信号通路、HIF-1信号通路、PI3K-Akt信号通路等。这些肿瘤浸润免疫细胞与风险评分系统的相关性分析表明,幼稚B细胞、浆细胞和CD8 + T细胞的浸润水平与风险评分系统呈负相关,而M2巨噬细胞与风险评分系统呈正相关。

结论

我们的研究建立了基于四个PALnc的风险评分系统,该系统反映免疫细胞浸润并预测PC患者的生存情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d685/7547431/acef49885b3d/12935_2020_1588_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d685/7547431/88d25358eb5d/12935_2020_1588_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d685/7547431/3f5fa6f582ba/12935_2020_1588_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d685/7547431/7e4350bca63c/12935_2020_1588_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d685/7547431/07cfbf7db814/12935_2020_1588_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d685/7547431/acef49885b3d/12935_2020_1588_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d685/7547431/88d25358eb5d/12935_2020_1588_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d685/7547431/3f5fa6f582ba/12935_2020_1588_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d685/7547431/7e4350bca63c/12935_2020_1588_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d685/7547431/07cfbf7db814/12935_2020_1588_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d685/7547431/acef49885b3d/12935_2020_1588_Fig5_HTML.jpg

相似文献

1
A four prognosis-associated lncRNAs (PALnc) based risk score system reflects immune cell infiltration and predicts patient survival in pancreatic cancer.一种基于四种预后相关长链非编码RNA(PALnc)的风险评分系统可反映免疫细胞浸润情况,并预测胰腺癌患者的生存情况。
Cancer Cell Int. 2020 Oct 9;20:493. doi: 10.1186/s12935-020-01588-y. eCollection 2020.
2
Significance of Tumor-Infiltrating Immune Cells in the Prognosis of Colon Cancer.肿瘤浸润免疫细胞在结肠癌预后中的意义
Onco Targets Ther. 2020 May 22;13:4581-4589. doi: 10.2147/OTT.S250416. eCollection 2020.
3
Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.鉴定胰腺癌中的免疫细胞浸润图谱以辅助免疫治疗。
Future Oncol. 2021 Nov;17(31):4131-4143. doi: 10.2217/fon-2021-0495. Epub 2021 Aug 4.
4
Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.血管生成相关长链非编码 RNA 预测胃腺癌的预后特征。
BMC Cancer. 2021 Dec 7;21(1):1312. doi: 10.1186/s12885-021-08987-y.
5
N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma.N6-甲基腺苷相关长链非编码 RNA 在胰腺导管腺癌的预后和免疫微环境中发挥重要作用。
Sci Rep. 2021 Sep 8;11(1):17844. doi: 10.1038/s41598-021-97362-9.
6
A Signature of Autophagy-Related Long Non-coding RNA to Predict the Prognosis of Breast Cancer.一种自噬相关长链非编码RNA特征用于预测乳腺癌预后
Front Genet. 2021 Mar 16;12:569318. doi: 10.3389/fgene.2021.569318. eCollection 2021.
7
Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas.基于 HIF-1 信号的预后分层评估胰腺导管腺癌的缺氧状态和免疫浸润。
Front Immunol. 2021 Dec 3;12:790661. doi: 10.3389/fimmu.2021.790661. eCollection 2021.
8
Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction.免疫浸润亚型特征分析和胃食管结合部腺癌预后相关长链非编码 RNA 的鉴定。
Front Immunol. 2021 May 28;12:651056. doi: 10.3389/fimmu.2021.651056. eCollection 2021.
9
A Four Autophagy-Related Gene-Based Prognostic Signature for Pancreatic Cancer.基于四个自噬相关基因的胰腺癌预后签名。
Crit Rev Eukaryot Gene Expr. 2021;31(4):89-100. doi: 10.1615/CritRevEukaryotGeneExpr.2021038733.
10
Comprehensive Analysis of Autophagy-Associated lncRNAs Reveal Potential Prognostic Prediction in Pancreatic Cancer.自噬相关长链非编码RNA的综合分析揭示了胰腺癌潜在的预后预测价值。
Front Oncol. 2021 May 26;11:596573. doi: 10.3389/fonc.2021.596573. eCollection 2021.

引用本文的文献

1
Disulfidptosis classification of pancreatic carcinoma reveals correlation with clinical prognosis and immune profile.胰腺癌的二硫化物诱导细胞程序性坏死分类揭示了与临床预后和免疫特征的相关性。
Hereditas. 2025 Feb 22;162(1):26. doi: 10.1186/s41065-025-00381-z.
2
Integrative bioinformatics and experimental analyses identify U2SURP as a novel lactylation-related prognostic signature in esophageal carcinoma.整合生物信息学和实验分析确定U2SURP是食管癌中一种新的与乳酸化相关的预后标志物。
Immunol Res. 2025 Feb 3;73(1):45. doi: 10.1007/s12026-024-09589-z.
3
Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancer.

本文引用的文献

1
Long Non-Coding RNA in the Pathogenesis of Cancers.长链非编码 RNA 在癌症发病机制中的作用。
Cells. 2019 Sep 1;8(9):1015. doi: 10.3390/cells8091015.
2
LINC00346 promotes pancreatic cancer progression through the CTCF-mediated Myc transcription.LINC00346 通过 CTCF 介导的 Myc 转录促进胰腺癌进展。
Oncogene. 2019 Oct;38(41):6770-6780. doi: 10.1038/s41388-019-0918-z. Epub 2019 Aug 7.
3
Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma.肿瘤浸润淋巴细胞和免疫相关基因作为胰腺腺癌预后的预测因子。
基于代谢和免疫亚型的胰腺癌新型预后生物标志物的基因组分析和筛选。
Cell Oncol (Dordr). 2023 Dec;46(6):1691-1708. doi: 10.1007/s13402-023-00836-3. Epub 2023 Jul 11.
4
Competing endogenous RNA analysis identified lncRNA DSCR9 as a novel prognostic biomarker associated with metastasis and tumor microenvironment in renal cell carcinoma.竞争性内源性RNA分析确定长链非编码RNA DSCR9是一种与肾细胞癌转移和肿瘤微环境相关的新型预后生物标志物。
Oncol Lett. 2023 May 22;26(1):290. doi: 10.3892/ol.2023.13876. eCollection 2023 Jul.
5
Downregulation of the long noncoding RNA DSCR9 (Down syndrome critical region 9) delays breast cancer progression by modulating microRNA-504-5p-dependent G protein-coupled receptor 65.长链非编码 RNA DSCR9(唐氏综合征关键区域 9)下调通过调节 microRNA-504-5p 依赖性 G 蛋白偶联受体 65 来延缓乳腺癌进展。
Hum Cell. 2023 Jul;36(4):1516-1534. doi: 10.1007/s13577-023-00916-4. Epub 2023 May 29.
6
A lactate-related LncRNA model for predicting prognosis, immune landscape and therapeutic response in breast cancer.一种用于预测乳腺癌预后、免疫格局和治疗反应的乳酸相关长链非编码RNA模型。
Front Genet. 2022 Oct 5;13:956246. doi: 10.3389/fgene.2022.956246. eCollection 2022.
7
Methylation of N6 adenosine-related long noncoding RNA: effects on prognosis and treatment in 'driver-gene-negative' lung adenocarcinoma.N6 腺苷相关长非编码 RNA 的甲基化:对“驱动基因阴性”肺腺癌预后和治疗的影响。
Mol Oncol. 2023 Feb;17(2):365-377. doi: 10.1002/1878-0261.13323. Epub 2022 Nov 16.
8
Antiproliferative effects of dried Moringa oleifera leaf extract on human Wharton's Jelly mesenchymal stem cells.辣木叶干提取物对人牙髓间充质干细胞的抗增殖作用。
PLoS One. 2022 Oct 5;17(10):e0274814. doi: 10.1371/journal.pone.0274814. eCollection 2022.
9
Identification of an autophagy-related gene signature for predicting prognosis and immune activity in pancreatic adenocarcinoma.鉴定一个自噬相关基因特征,用于预测胰腺腺癌的预后和免疫活性。
Sci Rep. 2022 Apr 29;12(1):7006. doi: 10.1038/s41598-022-11050-w.
10
Establishment and validation of a prognostic model based on HRR-related lncRNAs in colon adenocarcinoma.基于 HRR 相关 lncRNAs 的结肠癌预后模型的建立与验证。
World J Surg Oncol. 2022 Mar 9;20(1):74. doi: 10.1186/s12957-022-02534-0.
PLoS One. 2019 Aug 5;14(8):e0219566. doi: 10.1371/journal.pone.0219566. eCollection 2019.
4
A Competing-Risks Nomogram in Patients with Metastatic Pancreatic Duct Adenocarcinoma.转移性胰腺导管腺癌患者的竞争风险列线图
Med Sci Monit. 2019 May 18;25:3683-3691. doi: 10.12659/MSM.913533.
5
Identification of prognostic biomarkers of prostate cancer with long non-coding RNA-mediated competitive endogenous RNA network.基于长链非编码RNA介导的竞争性内源性RNA网络鉴定前列腺癌的预后生物标志物
Exp Ther Med. 2019 Apr;17(4):3035-3040. doi: 10.3892/etm.2019.7277. Epub 2019 Feb 14.
6
Deletion of C9orf53 promotes the growth of head and neck squamous cell carcinoma and is associated with poor prognosis of patients with head and neck squamous cell carcinoma.C9orf53基因的缺失促进头颈部鳞状细胞癌的生长,并与头颈部鳞状细胞癌患者的不良预后相关。
Oncol Lett. 2019 Jan;17(1):1223-1228. doi: 10.3892/ol.2018.9675. Epub 2018 Nov 8.
7
Novel three‑lncRNA signature predicts survival in patients with pancreatic cancer.新型三长链非编码 RNA 标志物可预测胰腺癌患者的生存情况。
Oncol Rep. 2018 Dec;40(6):3427-3437. doi: 10.3892/or.2018.6761. Epub 2018 Oct 3.
8
Tertiary Lymphoid Structures in Colorectal Cancers and Their Prognostic Value.结直肠癌中的三级淋巴结构及其预后价值。
Open Access Maced J Med Sci. 2018 Oct 9;6(10):1824-1828. doi: 10.3889/oamjms.2018.341. eCollection 2018 Oct 25.
9
Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription.缺氧诱导的长链非编码 RNA-BX111 通过调节 ZEB1 转录促进胰腺癌的转移和进展。
Oncogene. 2018 Nov;37(44):5811-5828. doi: 10.1038/s41388-018-0382-1. Epub 2018 Jul 3.
10
Computational immune profiling in lung adenocarcinoma reveals reproducible prognostic associations with implications for immunotherapy.肺腺癌的计算免疫图谱揭示了与免疫治疗相关的可重复预后关联。
Oncoimmunology. 2018 Mar 15;7(6):e1431084. doi: 10.1080/2162402X.2018.1431084. eCollection 2018.